Chonluten is a short synthetic peptide (Glu-Asp-Gly) from the Khavinson bioregulator family, sold in Russia as a dietary supplement. Very few studies test it, and its only result so far comes from a lab study on inflammation. PepBank shows 1 result on Chonluten from animal and lab studies. No study in people has reported results yet. Data as of 2026-10-30.
Also known as EDG, Chonluten, Chonluten peptide, Glu-Asp-Gly, Glutamyl-aspartyl-glycine, Honluten and 1 more
| What it is | Synthetic analog, 3 amino acids |
|---|---|
| Approval | Regulatory status not recorded |
| In sport | Status unknown |
| Studies | 2 studies with results. 1 of them gave Chonluten, with 1 result. 1 in lab cells |
| Clinical trials | None registered |
| Community use | Community interest in lung and bronchial health |
Synthetic Glu-Asp-Gly peptide from the Khavinson bioregulator family.
Amino acids in one chain
The key facts about the molecule. Long codes are in the closed section below.
Three-letter sequenceH-Glu-Asp-Gly-OH
InChIKeyDSPQRJXOIXHOHK-WDSKDSINSA-N
SMILESC(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N
Results grouped by what the studies measured. Each card shows where its results come from.
In cells exposed to bacterial LPS, Chonluten reduced production of the inflammatory protein TNF. International journal of molecular sciences, 2022
Studies in people come first, then studies in animals and in the lab.
Status unknown.
Status unknown.
Status unknown.
Regulatory status not recorded. Status unknown.
Laws and labels change, so check the regulator for the current status.
PepBank has no safety result from studies of Chonluten yet. That does not mean Chonluten is safe.
What people report online. It comes from forums and guides, not from studies.
The guide describes lung and bronchial health interest. It reports a use pattern, without proof of safety or benefit.
| Context | Route | Amount | How often | How long | Agreement | Sources |
|---|---|---|---|---|---|---|
| Community interest in lung and bronchial health | subcutaneous injection | 200 to 250 mcg per dose | once daily | 10 days | Single non-vendor guide. The underlying community reports were not independently verified. | S1 |
Gaps
This is one secondary guide. It does not identify the underlying community reports. Other regimens exist in the guide. No official medicine label was established. Product purity and actual use were not independently tested.
The answer links to every study it uses.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.
Ask your AI about Chonluten
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated